BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10354406)

  • 1. 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Teoh B; Criscione KR
    J Med Chem; 1999 Jun; 42(11):1982-90. PubMed ID: 10354406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the role of the acidic hydrogen in imparting selectivity of 7-(aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) toward inhibition of phenylethanolamine N-methyltransferase vs the alpha 2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Caldwell TM; Criscione KR
    J Med Chem; 1997 Dec; 40(25):3997-4005. PubMed ID: 9406590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
    J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
    Grunewald GL; Caldwell TM; Li Q; Criscione KR
    J Med Chem; 1999 Aug; 42(17):3315-23. PubMed ID: 10464018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a 3-alkyl-, 4-hydroxy- and/or 8-aromatic-substituent on the phenylethanolamine N-methyltransferase inhibitor potency and alpha2-adrenoceptor affinity of 2,3,4,5-tetrahydro-1H-2-benzazepines.
    Grunewald GL; Dahanukar VH; Criscione KR
    Bioorg Med Chem; 2001 Aug; 9(8):1957-65. PubMed ID: 11504632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-hydroxymethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline inhibitors of phenylethanolamine N-methyltransferase that display remarkable potency and selectivity.
    Grunewald GL; Romero FA; Criscione KR
    J Med Chem; 2005 Jan; 48(1):134-40. PubMed ID: 15634007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the active site of phenylethanolamine N-methyltransferase: 3-alkyl-7-substituted-1,2,3,4-tetrahydroisoquinoline inhibitors.
    Grunewald GL; Romero FA; Chieu AD; Fincham KJ; Bhat SR; Criscione KR
    Bioorg Med Chem; 2005 Feb; 13(4):1261-73. PubMed ID: 15670935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiospecific synthesis of 3-fluoromethyl-, 3-hydroxymethyl-, and 3-chloromethyl-1,2,3,4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
    Grunewald GL; Caldwell TM; Li Q; Dahanukar VH; McNeil B; Criscione KR
    J Med Chem; 1999 Oct; 42(21):4351-61. PubMed ID: 10543879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor.
    Romero FA; Vodonick SM; Criscione KR; McLeish MJ; Grunewald GL
    J Med Chem; 2004 Aug; 47(18):4483-93. PubMed ID: 15317460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines.
    Grunewald GL; Romero FA; Seim MR; Criscione KR; Deupree JD; Spackman CC; Bylund DB
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1143-7. PubMed ID: 15686930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
    Grunewald GL; Dahanukar VH; Ching P; Criscione KR
    J Med Chem; 1996 Aug; 39(18):3539-46. PubMed ID: 8784452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
    Grunewald GL; Seim MR; Regier RC; Martin JL; Gee CL; Drinkwater N; Criscione KR
    J Med Chem; 2006 Sep; 49(18):5424-33. PubMed ID: 16942016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biochemical evaluation of 3-fluoromethyl-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
    Grunewald GL; Caldwell TM; Li Q; Slavica M; Criscione KR; Borchardt RT; Wang W
    J Med Chem; 1999 Sep; 42(18):3588-601. PubMed ID: 10479290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomolar inhibitors of CNS epinephrine biosynthesis: (R)-(+)-3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines as potent and highly selective inhibitors of phenylethanolamine N-methyltransferase1.
    Grunewald GL; Romero FA; Criscione KR
    J Med Chem; 2005 Mar; 48(6):1806-12. PubMed ID: 15771426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of phenylethanolamine N-methyltransferase devoid of alpha2-adrenoceptor affinity.
    Grunewald GL; Lu J; Criscione KR; Okoro CO
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5319-23. PubMed ID: 16169723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
    Grunewald GL; Sall DJ; Monn JA
    J Med Chem; 1988 Apr; 31(4):824-30. PubMed ID: 3351861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3-Dimethyl-7-substituted-1,2,3,4-tetrahydroisoquinolines as probes for the binding orientation of tetrahydroisoquinoline at the active site of phenylethanolamine N-methyltransferase.
    Grunewald GL; Caldwell TM; Li Q; Criscione KR
    Bioorg Med Chem; 1999 May; 7(5):869-80. PubMed ID: 10400340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.
    Grunewald GL; Seim MR; Lu J; Makboul M; Criscione KR
    J Med Chem; 2006 May; 49(10):2939-52. PubMed ID: 16686536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.
    Grunewald GL; Seim MR; Regier RC; Criscione KR
    Bioorg Med Chem; 2007 Feb; 15(3):1298-310. PubMed ID: 17126018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.